Writer
Andorra, un pequeño e independiente país situado entre Francia y España en las montañas de los Pirineos, con una población total de 80.000 personas, se encontró en el centro de uno de los robos de bancos más intrincados e indignantes de la historia moderna: el 10 de marzo de 2015, Banca Privada d’Andorra (BPA), un banco privado en el país pirenaico, fue cerrado por los gobiernos español, estadounidense y andorrano en los esfuerzos de España por destruir los movimientos pro-independencia de Cataluña, dejando así a docenas de civiles enfrentados a penas de prisión por delitos de lavado de dinero que nunca existieron, y a muchas familias sin los ahorros de toda su vida.
Director
Andorra, un pequeño e independiente país situado entre Francia y España en las montañas de los Pirineos, con una población total de 80.000 personas, se encontró en el centro de uno de los robos de bancos más intrincados e indignantes de la historia moderna: el 10 de marzo de 2015, Banca Privada d’Andorra (BPA), un banco privado en el país pirenaico, fue cerrado por los gobiernos español, estadounidense y andorrano en los esfuerzos de España por destruir los movimientos pro-independencia de Cataluña, dejando así a docenas de civiles enfrentados a penas de prisión por delitos de lavado de dinero que nunca existieron, y a muchas familias sin los ahorros de toda su vida.
Director
A new documentary exploring Fetal Stem Cell injections for a variety of neurological and immunological ailments.
Editor
The modern biographical story of Stanislaw Burzynski, MD, PhD who discovered an innovative patent-protected cancer therapy currently enrolled in FDA clinical trials. This story sheds light on the current regulatory and industry roadblocks preventing these life-saving medications from reaching the market as of 2016. The current story of Stanislaw Burzynski, MD, PhD who discovered an innovative cancer therapy now enrolled in FDA clinical trials, and the regulatory and industry roadblocks preventing these life-saving medications from reaching the market.
Producer
The modern biographical story of Stanislaw Burzynski, MD, PhD who discovered an innovative patent-protected cancer therapy currently enrolled in FDA clinical trials. This story sheds light on the current regulatory and industry roadblocks preventing these life-saving medications from reaching the market as of 2016. The current story of Stanislaw Burzynski, MD, PhD who discovered an innovative cancer therapy now enrolled in FDA clinical trials, and the regulatory and industry roadblocks preventing these life-saving medications from reaching the market.
Writer
The modern biographical story of Stanislaw Burzynski, MD, PhD who discovered an innovative patent-protected cancer therapy currently enrolled in FDA clinical trials. This story sheds light on the current regulatory and industry roadblocks preventing these life-saving medications from reaching the market as of 2016. The current story of Stanislaw Burzynski, MD, PhD who discovered an innovative cancer therapy now enrolled in FDA clinical trials, and the regulatory and industry roadblocks preventing these life-saving medications from reaching the market.
Director
The modern biographical story of Stanislaw Burzynski, MD, PhD who discovered an innovative patent-protected cancer therapy currently enrolled in FDA clinical trials. This story sheds light on the current regulatory and industry roadblocks preventing these life-saving medications from reaching the market as of 2016. The current story of Stanislaw Burzynski, MD, PhD who discovered an innovative cancer therapy now enrolled in FDA clinical trials, and the regulatory and industry roadblocks preventing these life-saving medications from reaching the market.
Himself
The story of a young science-writer at Memorial Sloan-Kettering Cancer Center, who risked everything by blowing the whistle on a massive cover-up involving a promising cancer therapy.
Screenplay
The story of a young science-writer at Memorial Sloan-Kettering Cancer Center, who risked everything by blowing the whistle on a massive cover-up involving a promising cancer therapy.
Director
The story of a young science-writer at Memorial Sloan-Kettering Cancer Center, who risked everything by blowing the whistle on a massive cover-up involving a promising cancer therapy.
Director
In the compelling follow-up to the internationally award-winning documentary, "Burzynski: the Movie,", Part II explores the current status of Antineoplastons' clinical testing sanctioned by the United States Food & Drug Administration - and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas. Since the mapping of the Cancer Genome, Burzynski has pioneered an expansion of his therapy, which he calls, "Personalized Gene-Targeted Cancer Therapy", where each patient's Genomic Cancer Atlas is mapped and a treatment regimen is personally tailored for each individual patient - vs. the conveyor belt, "one-size-fits-all" approach that current oncology adheres to.
Director
Burzynski, the Movie is the story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history. His victorious battles with the United States government were centered around Dr. Burzynski's gene-targeted cancer medicines he discovered in the 1970's called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and could begin the final phase of FDA testing in 2011–barring the ability to raise the required $300 million to fund the final phase of FDA clinical trials.
Animation Director
El siempre polémico Michael Moore denuncia el sistema capitalista de Wall Street, adoptando un punto de vista que analiza la crisis finaciera mundial y la economía estadounidense en plena transición entre la administración entrante de Barack Obama y la saliente de George W. Bush.
